ARS Pharmaceuticals, Inc.
USD8.90
-0.53 (-5.62%)
CEO
Richard E. Lowenthal
IPO Date
2020-12-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$9.31
Prev. Close
$9.43
Day Low
$8.63
Day High
$9.43
52W Low
$6.66
52W High
$18.90
Market Cap
$0.88B
Volume
1.59M
| 240,000 |
| $11.49 |
| 5 Jan 2026 | Karas Eric | Chief Commercial Officer | A-Award | Acquired | 240,000 | $11.49 |
| 5 Jan 2026 | Fitzpatrick Alexander A | Chief Legal Officer | A-Award | Acquired | 240,000 | $11.49 |
| 5 Jan 2026 | Dorsey Brian | Chief Operating Officer | A-Award | Acquired | 240,000 | $11.49 |
| 5 Jan 2026 | Chakma Justin | Chief Business Officer | A-Award | Acquired | 240,000 | $11.49 |
| 5 Jan 2026 | Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | A-Award | Acquired | 240,000 | $11.49 |
| 5 Jan 2026 | Tanimoto Sarina | 10 percent owner, officer: CHIEF MEDICAL OFFICER | A-Award | Acquired | 875,000 | $11.49 |
| 5 Jan 2026 | Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | Acquired | 875,000 | $11.49 |
| 5 Jan 2026 | Lowenthal Richard E | director, 10 percent owner, officer: PRESIDENT AND CEO | A-Award | Acquired | 240,000 | $11.49 |